Lyell Immunopharma IncEigentümerstruktur
| Preis (2026-07-30) | 52W Hoch | 52W Tief |
| 13.72 USD | 45 USD | 9,28 USD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 38,143 USD | 0 | 0 | 3 | 1 | 0 |
| #Shares | Short [%] | Short Ratio |
| 24.504.358 | 5,82 | 4,65 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Lyell Immunopharma Inc
Mitarbeiter 161
Handelsplatz NASDAQ
Ticker Symbol LYEL
IPO Datum 2021-06-17
Adresse 201 Haskins Way, South San Francisco, CA, United States, 94080
Webseite https://www.lyell.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Dr. Richard D. Klausner M.D. | Founder & Executive Chairman |
| 2 | Dr. Lynn Seely M.D., Ph.D. | Principal Executive Officer, President, CEO & Director |
| 3 | Mr. Stephen J. Hill | Chief Operating Officer |
| 4 | Dr. Gary K. Lee Ph.D. | Chief Scientific Officer |
| 5 | Prof. Stanley R. Riddell M.D. | Founder & Scientific Advisor |
| 6 | Dr. Crystal L. Mackall M.D. | Founder & Scientific Advisor |
| 7 | Ms. Smital Shah M.B.A. | Principal Financial Officer, CFO & Chief Business Officer |
| 8 | Nellie Dillery | Director of Accounting |
| 9 | Mr. Mark A. Meltz J.D. | General Counsel & Corporate Secretary |
| 10 | Ms. Ann Tomlin | Chief Human Resources Officer |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | ARCH VENTURE CORP | 0,00% | 0,00 Mio. USD |
| 2 | GSK PLC | 0,00% | 0,00 Mio. USD |
| 3 | MWG Caph Ltd | 0,00% | 0,00 Mio. USD |
| 4 | Vanguard Group Inc | 0,00% | 0,00 Mio. USD |
| 5 | Foresite Capital Management IV, LLC | 0,00% | 0,00 Mio. USD |
| 6 | Orland Properties Ltd | 0,00% | 0,00 Mio. USD |
| 7 | Vanguard Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 8 | Almitas Capital LLC | 0,00% | 0,00 Mio. USD |
| 9 | Foresite Capital Management V, LLC | 0,00% | 0,00 Mio. USD |
| 10 | Millennium Management LLC | 0,00% | 0,00 Mio. USD |
| 11 | Citadel Advisors Llc | 0,00% | 0,00 Mio. USD |
| 12 | venBio Partners LLC | 0,00% | 0,00 Mio. USD |
| 13 | Susquehanna International Group, LLP | 0,00% | 0,00 Mio. USD |
| 14 | Alphabet Inc | 0,00% | 0,00 Mio. USD |
| 15 | BlackRock Inc | 0,00% | 0,00 Mio. USD |
| 16 | Geode Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 17 | HSG Holding Ltd | 0,00% | 0,00 Mio. USD |
| 18 | Marshall Wace Asset Management Ltd | 0,00% | 0,00 Mio. USD |
| 19 | Renaissance Technologies Corp | 0,00% | 0,00 Mio. USD |
| 20 | The Goldman Sachs Group Inc | 0,00% | 0,00 Mio. USD |